These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16721205)

  • 1. Secondary prevention of myocardial infarction: a survey in primary care.
    Filippi A; Vanuzzo D; Bignamini AA; Mazzaglia G; Brignoli O; Sabatini A; Cricelli C; Catapano AL
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):422-6. PubMed ID: 16721205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P; Kawecka-Jaszcz K; Pajak A
    Przegl Lek; 2001; 58 Suppl 6():21-5. PubMed ID: 11873737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of coronary heart disease. A survey in an Italian primary care practice.
    Modesti A; Del Papa C; Modesti L; Bartaloni R; Galloni V; Dell'omo G; Pedrinelli R
    Minerva Cardioangiol; 2010 Apr; 58(2):167-73. PubMed ID: 20440246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part III. Secondary prevention of ischaemic heart disease after discharge].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):964-8. PubMed ID: 11987836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug secondary prevention in postmenopausal women with ischemic heart disease.
    Zdrenghea D; Pop D; Sitar-Tăut A; Cebanu M; Zdrenghea V
    Rom J Intern Med; 2009; 47(1):41-5. PubMed ID: 19886068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with suspected angina, but without known myocardial infarction: a cross-sectional survey.
    Filippi A; Gensini G; Bignanimi AA; Sabatini A; Mazzaglia G; Cricelli C
    Br J Gen Pract; 2004 Jun; 54(503):429-33. PubMed ID: 15186563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M; Richard H; Pilote L
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N; Martins S; Belo A; Fiuza M;
    Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin overprescription in primary cardiovascular prevention.
    Manes C; Giacci L; Sciartilli A; D'Alleva A; De Caterina R
    Thromb Res; 2006; 118(4):471-7. PubMed ID: 16321425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
    Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
    J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of post-infarction blood lipids].
    Puddu PE; Menotti A
    Cardiologia; 1997 Dec; 42(12):1263-9. PubMed ID: 9534321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database.
    Tuppin P; Neumann A; Danchin N; Weill A; Ricordeau P; de Peretti C; Allemand H
    Arch Cardiovasc Dis; 2009 Apr; 102(4):279-92. PubMed ID: 19427605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
    Varis J; Savola H; Vesalainen R; Kantola I
    Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The patterns of antihypertensive drug prescription by cardiologists in Kerman province of Iran, 2006.
    Sepehri G; Talebizadeh N; Mirzazadeh A; Mohsenbeigi M
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):180-5. PubMed ID: 18001003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intervention program to improve secondary prevention of myocardial infarction. Results of the PRESENTE (early secondary prevention) study].
    de Velasco JA; Cosín J; de Oya M; de Teresa E;
    Rev Esp Cardiol; 2004 Feb; 57(2):146-54. PubMed ID: 14967110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.